Melanoma detection by skin self-examination targeting at-risk women: A randomized controlled trial with telemedicine support for concerning moles

Secondary melanoma prevention remains crucial to reduce morbidity and mortality for the 200,000 people in the United States estimated to develop melanoma in 2021. This 3-month randomized controlled trial of online skin self-examination (SSE) education among 1000 at-risk women who received care at No...

Full description

Bibliographic Details
Main Authors: June K. Robinson, Samer Wahood, Sophia Ly, Jessie Kirk, Jamie Yoon, James Sterritt, Elizabeth Gray, Mary Kwasny
Format: Article
Language:English
Published: Elsevier 2021-12-01
Series:Preventive Medicine Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211335521002229
id doaj-63dd96891df14e7b927ee7d5bd75bada
record_format Article
spelling doaj-63dd96891df14e7b927ee7d5bd75bada2021-09-03T04:44:40ZengElsevierPreventive Medicine Reports2211-33552021-12-0124101532Melanoma detection by skin self-examination targeting at-risk women: A randomized controlled trial with telemedicine support for concerning molesJune K. Robinson0Samer Wahood1Sophia Ly2Jessie Kirk3Jamie Yoon4James Sterritt5Elizabeth Gray6Mary Kwasny7Department of Dermatology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA; Corresponding author at: Department of Dermatology, Northwestern University Feinberg School of Medicine, 645 N Michigan Ave, Chicago, IL 60611, USA.Department of Dermatology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USADepartment of Dermatology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USADepartment of Dermatology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USADepartment of Dermatology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USADepartment of Dermatology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USADepartment of Preventive Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL, USADepartment of Preventive Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL, USASecondary melanoma prevention remains crucial to reduce morbidity and mortality for the 200,000 people in the United States estimated to develop melanoma in 2021. This 3-month randomized controlled trial of online skin self-examination (SSE) education among 1000 at-risk women who received care at Northwestern Medicine in Illinois sought to determine SSE initiation and monthly performance, SSE anxiety and confidence, and health care practitioner (HCP) visits for concerning moles. Positive responses to a personal history of sunburn, a personal or family history of skin cancer, and/or having 10 or more lifetime indoor tanning sessions identified and informed women of their increased risk of melanoma. At one month, 96.2% of women receiving SSE education (SSE women) initiated SSE compared to 48.1% in the active control arm (control) (p < 0.001). More control women sought HCP visits (n = 107) than SSE women (n = 39). Control women seen by HCPs identified benign lesions, especially seborrheic keratosis, more often than SSE women. More atypical nevi (SSE 38.5%, control 8.4%) and melanomas (SSE 25.6%, control 4.7%) were visually identified by SSE women seeing HPCs (p < 0.001). There was no significant difference in SSE anxiety between the control and SSE arms. Confidence increased significantly in the SSE arm whereas there was no change in the control group (p < 0.001). Women checked someone else for concerning moles [315/ 494 (63.8%) of SSE women]. Targeting at-risk women for SSE education may help reduce melanoma mortality, especially in rural communities where incidence and mortality are greater than in urban areas.http://www.sciencedirect.com/science/article/pii/S2211335521002229MelanomaScreeningCOVID-19RuralWomenRandomized controlled trial
collection DOAJ
language English
format Article
sources DOAJ
author June K. Robinson
Samer Wahood
Sophia Ly
Jessie Kirk
Jamie Yoon
James Sterritt
Elizabeth Gray
Mary Kwasny
spellingShingle June K. Robinson
Samer Wahood
Sophia Ly
Jessie Kirk
Jamie Yoon
James Sterritt
Elizabeth Gray
Mary Kwasny
Melanoma detection by skin self-examination targeting at-risk women: A randomized controlled trial with telemedicine support for concerning moles
Preventive Medicine Reports
Melanoma
Screening
COVID-19
Rural
Women
Randomized controlled trial
author_facet June K. Robinson
Samer Wahood
Sophia Ly
Jessie Kirk
Jamie Yoon
James Sterritt
Elizabeth Gray
Mary Kwasny
author_sort June K. Robinson
title Melanoma detection by skin self-examination targeting at-risk women: A randomized controlled trial with telemedicine support for concerning moles
title_short Melanoma detection by skin self-examination targeting at-risk women: A randomized controlled trial with telemedicine support for concerning moles
title_full Melanoma detection by skin self-examination targeting at-risk women: A randomized controlled trial with telemedicine support for concerning moles
title_fullStr Melanoma detection by skin self-examination targeting at-risk women: A randomized controlled trial with telemedicine support for concerning moles
title_full_unstemmed Melanoma detection by skin self-examination targeting at-risk women: A randomized controlled trial with telemedicine support for concerning moles
title_sort melanoma detection by skin self-examination targeting at-risk women: a randomized controlled trial with telemedicine support for concerning moles
publisher Elsevier
series Preventive Medicine Reports
issn 2211-3355
publishDate 2021-12-01
description Secondary melanoma prevention remains crucial to reduce morbidity and mortality for the 200,000 people in the United States estimated to develop melanoma in 2021. This 3-month randomized controlled trial of online skin self-examination (SSE) education among 1000 at-risk women who received care at Northwestern Medicine in Illinois sought to determine SSE initiation and monthly performance, SSE anxiety and confidence, and health care practitioner (HCP) visits for concerning moles. Positive responses to a personal history of sunburn, a personal or family history of skin cancer, and/or having 10 or more lifetime indoor tanning sessions identified and informed women of their increased risk of melanoma. At one month, 96.2% of women receiving SSE education (SSE women) initiated SSE compared to 48.1% in the active control arm (control) (p < 0.001). More control women sought HCP visits (n = 107) than SSE women (n = 39). Control women seen by HCPs identified benign lesions, especially seborrheic keratosis, more often than SSE women. More atypical nevi (SSE 38.5%, control 8.4%) and melanomas (SSE 25.6%, control 4.7%) were visually identified by SSE women seeing HPCs (p < 0.001). There was no significant difference in SSE anxiety between the control and SSE arms. Confidence increased significantly in the SSE arm whereas there was no change in the control group (p < 0.001). Women checked someone else for concerning moles [315/ 494 (63.8%) of SSE women]. Targeting at-risk women for SSE education may help reduce melanoma mortality, especially in rural communities where incidence and mortality are greater than in urban areas.
topic Melanoma
Screening
COVID-19
Rural
Women
Randomized controlled trial
url http://www.sciencedirect.com/science/article/pii/S2211335521002229
work_keys_str_mv AT junekrobinson melanomadetectionbyskinselfexaminationtargetingatriskwomenarandomizedcontrolledtrialwithtelemedicinesupportforconcerningmoles
AT samerwahood melanomadetectionbyskinselfexaminationtargetingatriskwomenarandomizedcontrolledtrialwithtelemedicinesupportforconcerningmoles
AT sophialy melanomadetectionbyskinselfexaminationtargetingatriskwomenarandomizedcontrolledtrialwithtelemedicinesupportforconcerningmoles
AT jessiekirk melanomadetectionbyskinselfexaminationtargetingatriskwomenarandomizedcontrolledtrialwithtelemedicinesupportforconcerningmoles
AT jamieyoon melanomadetectionbyskinselfexaminationtargetingatriskwomenarandomizedcontrolledtrialwithtelemedicinesupportforconcerningmoles
AT jamessterritt melanomadetectionbyskinselfexaminationtargetingatriskwomenarandomizedcontrolledtrialwithtelemedicinesupportforconcerningmoles
AT elizabethgray melanomadetectionbyskinselfexaminationtargetingatriskwomenarandomizedcontrolledtrialwithtelemedicinesupportforconcerningmoles
AT marykwasny melanomadetectionbyskinselfexaminationtargetingatriskwomenarandomizedcontrolledtrialwithtelemedicinesupportforconcerningmoles
_version_ 1717818080678117376